TUESDAY, JANUARY 30, 2018

5:45AM-6:00AMArrivals and Breakfast

6:00AM-7:15AMEducational Activity

LOCATION

Haleakala Ballroom 4/5, Grand Wailea

Wailea, Hawaii

DOWNLOADS

Will be available directly following the activity.

FACULTY

Neil J. Korman, MD, PhD

Director, Clinical Trials Unit

Clinical Director, Murdough
Family Center for Psoriasis

Professor, Dermatology

University Hospitals Cleveland
Medical Center

Case Western Reserve University
School of Medicine

Cleveland, Ohio

Rebecca Muntean, MD, ND, FACR

Clinical Rheumatologist,

Providence Health & Services

Faculty,

University of Washington WWAMI Regional Medical Education

Faculty,

Providence Spokane Internal Medicine Investigator,

Premier Clinical Research

Spokane, Washington

April Armstrong, MD, MPH

Associate Dean for Clinical Research,

Associate Professor of Dermatology,

Director of Clinical Research, Clinical and Translational Science Institute

Director of Clinical Trials
and Outcomes Research,

Director of Psoriasis Program,

Department of Dermatology

Keck School of Medicine of USC

Los Angeles, California

AGENDA

5:45AM-7:15AM

Arrivals and Breakfast

Provided by Forefront Collaborative

 

Welcome and Session Overview

 

Role of Dermatology Providers in Identifying and Managing Psoriatic Arthritis

Neil J. Korman, MD, PhD

 

Exercise: Individual Work on Case 1 Simulation on iPads®

 

Advances in Treatment of Psoriatic Arthritis and GRAPPA Recommendations for Treatment of Psoriatic Arthritis by Disease Domain

Rebecca Muntean, MD, ND, FACR

 

Exercise: Individual Work on Case 2 Simulation on iPads

 

Patient-Provider Shared Decision Making for Treatment of Psoriasis and Psoriatic Arthritis

 April Armstrong, MD, MPH

 

Facilitated Large-Group Discussion of the Simulation Exercise

 

Question and Answer Session

 

Closing Remarks and Time to Complete Posttest and Evaluation

ACTIVITY AND CME INFORMATION

TARGET AUDIENCE

WORKSHOP DESCRIPTION

LEARNING OBJECTIVES

 

The target audience is dermatologists. Other healthcare professionals, including rheumatologists, physician assistants, and nurse practitioners who treat patients with PsA, may benefit from participation in this educational activity.

 

The workshop will include two case simulations. Each participant will work on the simulations using a provided iPad®. In each simulation, participants will be able to explore a clinical vignette of a patient with psoriasis and psoriatic arthritis (PsA) and make a treatment decision choosing from the available options. Each case simulation will be discussed with the entire group of participants. As part of the workshop, the multidisciplinary faculty team will deliver three fast-paced, practice-oriented presentations. The first presentation will review the role of dermatology providers in PsA care, highlighting the importance of screening patients with psoriasis for PsA in order to timely diagnose PsA and start treatment that can prevent or reduce joint damage. The second presentation will address the wide range of PsA therapies and latest evidence-based recommendations for treatment of PsA. The third presentation will introduce an approach for patient-provider shared decision-making in the treatment of psoriasis and PsA. Throughout the workshop, participants will be invited to answer questions, as well as ask questions and make comments, verbally and via iPads®.

 

As a result of participation in this educational activity, participants should increase their ability to:

2.

DISCUSS Group for Research
and Assessment of Psoriasis
and Psoriatic Arthritis (GRAPPA)

recommendations for treatment
of PsA.

 

1.

SCREEN patients with psoriasis for PsA at each visit.

3.

INCORPORATE advances in treatment of PsA into care of patients with psoriasis and PsA to achieve desired treatment targets.

4.

Effectively ENGAGE
patients with psoriasis and
PsA in shared decision making regarding goals of treatment, development of treatment plan,
and treatment modification.

CREDIT DESIGNATION STATEMENT

ACCREDITATION STATEMENT

 

DISCLOSURE STATEMENT

Forefront Collaborative designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

 

Forefront Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

 

Educational activities provided by Forefront Collaborative must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). The disclosures will be listed in the online resources.

The content of this activity was independently peer reviewed by two reviewers. The reviewers of this activity have no relevant financial relationships to disclose.

 

This continuing medical education activity may include reference(s) to unlabeled or unapproved uses of drugs.

 

The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views or recommendations of Forefront Collaborative.

 

This activity will be conducted in conjunction with the 14th Annual Maui Derm for Dermatologists 2018 Conference.

 

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Forefront Collaborative complies with the Americans with Disabilities Act and will make every reasonable effort to accommodate your request. For special requests, please call Christine Tebben at 317.208.2768 prior to this activity.

630 W. Carmel Drive, Suite 260

Carmel, Indiana 46032